DOI QR코드

DOI QR Code

Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter Study

  • Jeongsu Kim (Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine) ;
  • Jin Ho Jang (Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine) ;
  • Kipoong Kim (Division of Cardiology, Department of Internal Medicine, Yonsei University Health System) ;
  • Sunghoon Park (Department of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital) ;
  • Su Hwan Lee (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine) ;
  • Onyu Park (Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital) ;
  • Tae Hwa Kim (Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine) ;
  • Hye Ju Yeo (Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine) ;
  • Woo Hyun Cho (Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine)
  • Received : 2023.08.18
  • Accepted : 2023.12.20
  • Published : 2024.04.30

Abstract

Background: Results of studies investigating the association between body mass index (BMI) and mortality in patients with coronavirus disease-2019 (COVID-19) have been conflicting. Methods: This multicenter, retrospective observational study, conducted between January 2020 and August 2021, evaluated the impact of obesity on outcomes in patients with severe COVID-19 in a Korean national cohort. A total of 1,114 patients were enrolled from 22 tertiary referral hospitals or university-affiliated hospitals, of whom 1,099 were included in the analysis, excluding 15 with unavailable height and weight information. The effect(s) of BMI on patients with severe COVID-19 were analyzed. Results: According to the World Health Organization BMI classification, 59 patients were underweight, 541 were normal, 389 were overweight, and 110 were obese. The overall 28-day mortality rate was 15.3%, and there was no significant difference according to BMI. Univariate Cox analysis revealed that BMI was associated with 28-day mortality (hazard ratio, 0.96; p=0.045), but not in the multivariate analysis. Additionally, patients were divided into two groups based on BMI ≥25 kg/m2 and underwent propensity score matching analysis, in which the two groups exhibited no significant difference in mortality at 28 days. The median (interquartile range) clinical frailty scale score at discharge was higher in nonobese patients (3 [3 to 5] vs. 4 [3 to 6], p<0.001). The proportion of frail patients at discharge was significantly higher in the nonobese group (28.1% vs. 46.8%, p<0.001). Conclusion: The obesity paradox was not evident in this cohort of patients with severe COVID-19. However, functional outcomes at discharge were better in the obese group.

Keywords

Acknowledgement

This study was supported by the Korean Academy of Tuberculosis and Respiratory Diseases (grant number: KATRD-S-2021-2). This work was supported by a Pusan National University Research Grant (2022).

References

  1. Yeo HJ, Kim TH, Jang JH, Jeon K, Oh DK, Park MH, et al. Obesity paradox and functional outcomes in sepsis: a multicenter prospective study. Crit Care Med 2023;51:742-52. https://doi.org/10.1097/CCM.0000000000005801
  2. Sawadogo W, Tsegaye M, Gizaw A, Adera T. Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: systematic review and meta-analysis. BMJ Nutr Prev Health 2022;5:10-8. https://doi.org/10.1136/bmjnph-2021-000375
  3. Yang J, Tian C, Chen Y, Zhu C, Chi H, Li J. Obesity aggravates COVID-19: an updated systematic review and meta-analysis. J Med Virol 2021;93:2662-74. https://doi.org/10.1002/jmv.26677
  4. Prasad NR, Elkholey K, Patel NR, Junqueira E, Cohen ES, Whitmore SP. Obesity associated with improved mortality of extracorporeal membrane oxygenation for severe COVID-19 pneumonia. Perfusion 2023:2676591231178896.
  5. Vulturar DM, Crivii CB, Orasan OH, Palade E, Buzoianu AD, Zehan IG, et al. Obesity impact on SARS-CoV-2 infection: pros and cons "obesity paradox": a systematic review. J Clin Med 2022;11:3844.
  6. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021;11:16144.
  7. de Oliveira Almeida K, Nogueira Alves IG, de Queiroz RS, de Castro MR, Gomes VA, Santos Fontoura FC, et al. A systematic review on physical function, activities of daily living and health-related quality of life in COVID-19 survivors. Chronic Illn 2023;19:279-303. https://doi.org/10.1177/17423953221089309
  8. Ciarambino T, Crispino P, Minervini G, Giordano M. COVID-19 and frailty. Vaccines (Basel) 2023;11:606.
  9. Zhou Y, Cowling BJ, Wu P, Chan WM, Lee SY, Lau EH, et al. Adiposity and influenza-associated respiratory mortality: a cohort study. Clin Infect Dis 2015;60:e49-57. https://doi.org/10.1093/cid/civ060
  10. Kompaniyets L, Goodman AB, Belay B, Freedman DS, Sucosky MS, Lange SJ, et al. Body mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death: United States, March-December 2020. MMWR Morb Mortal Wkly Rep 2021;70:355-61. https://doi.org/10.15585/mmwr.mm7010e4
  11. Fezeu L, Julia C, Henegar A, Bitu J, Hu FB, Grobbee DE, et al. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev 2011;12:653-9. https://doi.org/10.1111/j.1467-789X.2011.00864.x
  12. Ho JS, Fernando DI, Chan MY, Sia CH. Obesity in COVID-19: a systematic review and meta-analysis. Ann Acad Med Singap 2020;49:996-1008. https://doi.org/10.47102/annals-acadmedsg.2020299
  13. Hussain A, Mahawar K, Xia Z, Yang W, El-Hasani S. Obesity and mortality of COVID-19: meta-analysis. Obes Res Clin Pract 2020;14:295-300. https://doi.org/10.1016/j.orcp.2020.07.002
  14. Piotrowicz K, Gasowski J, Michel JP, Veronese N. PostCOVID-19 acute sarcopenia: physiopathology and management. Aging Clin Exp Res 2021;33:2887-98. https://doi.org/10.1007/s40520-021-01942-8
  15. Martinchek M, Beiting KJ, Walker J, Graupner J, Huisingh-Scheetz M, Thompson K, et al. Weight loss in COVID-19-positive nursing home residents. J Am Med Dir Assoc 2021;22:257-8. https://doi.org/10.1016/j.jamda.2020.11.031
  16. Paneroni M, Simonelli C, Saleri M, Bertacchini L, Venturelli M, Troosters T, et al. Muscle strength and physical performance in patients without previous disabilities recovering from COVID-19 pneumonia. Am J Phys Med Rehabil 2021;100:105-9. https://doi.org/10.1097/PHM.0000000000001641